In addition, in a CFA-induced rat RA model, MEG3 was low in synovial tissue and FLS, while the level of NLRC5 was increased, suggesting that MEG3 may potentially regulate the progression of RA by targeting NLRC5 (113). The gene discussed is NLRC5; the disease is rheumatoid arthritis.